---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-22-008770"
form_type: "8-K"
ticker: "DRMA"
cik: "0001853816"
company_name: "Dermata Therapeutics, Inc."
filed_at: "2022-06-24T23:59:59+00:00"
generated_at: "2026-06-24T23:25:22.582349+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Dermata promotes Nardo to Chief Development Officer; CEO takes 20% pay cut

## Summary
- Christopher Nardo promoted to SVP, Chief Development Officer effective July 1, 2022.
- Nardo granted option for 30,000 shares; vests 25% after one year, then monthly over 36 months.
- Nardo's base salary increased to $320,000 from $280,000 per year.
- CEO Gerald Proehl reduces salary from $350,000 to $280,000 per year effective same date.

## SEC filing metadata
- accession: 0001654954-22-008770
- form_type: 8-K
- ticker: DRMA
- cik: 0001853816
- company_name: Dermata Therapeutics, Inc.
- filed_at: 2022-06-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1853816/000165495422008770/0001654954-22-008770-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1853816/000165495422008770/drma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-22-008770
- JSON: https://secwatch.observer/filing/0001654954-22-008770.json
- Plain text: https://secwatch.observer/filing/0001654954-22-008770.txt

## Key facts
- Executive change
  Christopher J. Nardo changed role as Senior Vice President, Chief Development Officer at Dermata Therapeutics, Inc..
  - Action: promoted
  - Role: Senior Vice President, Chief Development Officer
  source text: Christopher J. Nardo, Ph.D., the Company’s Senior Vice President of Development, was promoted to Senior Vice President, Chief Development Officer, effective July 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1853816/000165495422008770/0001654954-22-008770-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.